Enlivex Therapeutics LTD. 6-K Filing
Ticker: ENLV · Form: 6-K · Filed: Dec 18, 2025 · CIK: 1596812
Sentiment: neutral
Filing Stats: 332 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2025-12-18 16:30:02
Filing Documents
- ea0270119-6k_enlivex.htm (6-K) — 11KB
- ea027011901ex99-1_enlivex.htm (EX-99.1) — 208KB
- ea027011901ex99-2_enlivex.htm (EX-99.2) — 17KB
- 0001213900-25-123303.txt ( ) — 238KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Enlivex Therapeutics Ltd. (Registrant) By: /s/ Oren Hershkovitz Name: Title: Oren Hershkovitz Chief Executive Officer Date: December 18, 2025 2